Package 60505-4779-5

{"route": ["ORAL"], "spl_id": "13431d63-13a5-2a76-c6de-06799bc59e29", "openfda": {"nui": ["N0000175605", "N0000175076", "N0000182141", "N0000182137", "N0000187062"], "upc": ["0360505477975", "0360505477951"], "unii": ["7RN5DR86CK"], "rxcui": ["867502"], "spl_set_id": ["b05ea49a-a764-5ff2-6e4a-26add69da9e2"], "pharm_class_epc": ["Kinase Inhibitor [EPC]"], "pharm_class_moa": ["Protein Kinase Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET in 1 BOTTLE (60505-4779-5)", "package_ndc": "60505-4779-5", "marketing_start_date": "20231019"}, {"sample": false, "description": "120 TABLET in 1 BOTTLE (60505-4779-7)", "package_ndc": "60505-4779-7", "marketing_start_date": "20231019"}], "brand_name": "Pazopanib", "product_id": "60505-4779_13431d63-13a5-2a76-c6de-06799bc59e29", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]"], "product_ndc": "60505-4779", "generic_name": "Pazopanib", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pazopanib", "active_ingredients": [{"name": "PAZOPANIB", "strength": "200 mg/1"}], "application_number": "ANDA217713", "marketing_category": "ANDA", "marketing_start_date": "20231019", "listing_expiration_date": "20261231"}